This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
NVIV.Q Overzicht aandelen
Operates as a research and clinical-stage biomaterials and biotechnology company in the United States.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 0/6 |
InVivo Therapeutics Holdings Corp. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$0.37 |
| 52 Week Hoogtepunt | US$1.41 |
| 52 Week Laag | US$0.15 |
| Bèta | 0.37 |
| 11 maand verandering | -7.38% |
| 3 maanden verandering | -0.87% |
| 1 Jaar Verandering | -71.54% |
| 33 jaar verandering | -97.73% |
| 5 jaar verandering | -99.92% |
| Verandering sinds IPO | -100.00% |
Recent nieuws en updates
Recent updates
InVivo Therapeutics dips 24% on $9M direct and private placement offerings
Oct 07We're Not Very Worried About InVivo Therapeutics Holdings' (NASDAQ:NVIV) Cash Burn Rate
Aug 26
Is InVivo Therapeutics Holdings (NASDAQ:NVIV) In A Good Position To Invest In Growth?
May 05Will InVivo Therapeutics Holdings (NASDAQ:NVIV) Spend Its Cash Wisely?
Jan 18Rendement voor aandeelhouders
| NVIV.Q | US Medical Equipment | US Markt | |
|---|---|---|---|
| 7D | -2.6% | -1.6% | -0.9% |
| 1Y | -71.5% | 32.6% | 38.9% |
Rendement versus industrie: NVIV.Q underperformed the US Medical Equipment industry which returned -3.1% over the past year.
Rendement versus markt: NVIV.Q underperformed the US Market which returned 22% over the past year.
Prijsvolatiliteit
| NVIV.Q volatility | |
|---|---|
| NVIV.Q Average Weekly Movement | 8.7% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.0% |
Stabiele aandelenkoers: NVIV.Q's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: NVIV.Q's weekly volatility has decreased from 26% to 9% over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2003 | 6 | Rich Toselli | www.invivotherapeutics.com |
InVivo Therapeutics Holdings Corp. Samenvatting
| NVIV.Q fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$1.15m |
| Inkomsten(TTM) | -US$9.33m |
| Inkomsten(TTM) | n/a |
0.0x
P/S-verhouding-0.1x
Koers/WinstverhoudingIs NVIV.Q overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| NVIV.Q resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$0 |
| Kosten van inkomsten | US$0 |
| Brutowinst | US$0 |
| Overige uitgaven | US$9.33m |
| Inkomsten | -US$9.33m |
Laatst gerapporteerde inkomsten
Sep 30, 2023
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -3.00 |
| Brutomarge | 0.00% |
| Nettowinstmarge | 0.00% |
| Schuld/Eigen Vermogen Verhouding | 0% |
Hoe presteerde NVIV.Q op de lange termijn?
Bekijk historische prestaties en vergelijking